Cure My Disease

Don't miss your cure!

 Log in / Sign up

New support team aims to bridge the gap from hospital to mental health care for psychosis

NCT ID NCT07713849

Recruiting now Disease control Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests a Transition Care Team (TCT) designed to help people with first episode psychosis successfully move from hospital to outpatient mental health services. The TCT provides short-term support including therapy, case management, and coordination with community programs. The main goal is to see if this approach increases the number of patients who start outpatient treatment within six weeks of leaving the hospital, compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Transition Care Team (TCT), a multidisciplinary support model including psychoeducation, case management, peer support, and care coordination
What this could lead to
If successful, this approach could help more people with first episode psychosis stay connected to care after hospitalization, potentially improving their long-term outcomes.
What could go wrong
This is a small, early-stage study with 75 participants, so results may not apply broadly. The intervention may not significantly improve engagement compared to standard discharge referrals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER WITH PSYCHOTIC FEATURES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder major depressive disorder psychiatric disorder psychotic disorder Psychotic Disorders schizoaffective disorder schizophrenia schizophreniform disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIPOLAR DISORDER WITH PSYCHOTIC FEATURES MAJOR DEPRESSIVE DISORDER WITH PSYCHOTIC FEATURES PSYCHOSIS NOS SCHIZOAFFECTIVE DISORDERS SCHIZOPHRENIA DISORDERS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Chicago Ingalls Memorial Hospital

    RECRUITING

    Harvey, Illinois, 60426, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • University of Chicago Medical Center, Biological Science Division

    ACTIVE_NOT_RECRUITING

    Chicago, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.